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OBJECTIVES To determine the morphologic features of coronary plaques associated with acute coronary
syndrome, we prospectively followed patients with atherosclerotic disease identified by
intravascular ultrasound (IVUS).
BACKGROUND Although clinical evaluation of the vulnerable atherosclerotic plaque is important, few data
exist regarding the morphology of the vulnerable plaque in clinical settings.
METHODS We examined 114 coronary sites without significant stenosis by angiography (,50% diameter
stenosis) in 106 patients. All the sites exhibited atherosclerotic lesions by IVUS. These lesions
consisted of 22 concentric and 92 eccentric plaques with a percent plaque area averaging 59 6
12%.
RESULTS During the follow-up period of 21.8 6 6.4 months (range 1 to 24), 12 patients had an acute
coronary event at a previously examined coronary site at an average of 4.0 6 3.4 months after
the initial IVUS study. All the preexisting plaques related to the acute events exhibited an
eccentric pattern and the mean percent plaque area was 67 6 9%, which was greater than
plaque area in the other 90 patients without acute events (57 6 12%, p , 0.05). There was
no statistically significant difference in lumen area between two patient groups (6.7 6 3.0 vs.
7.5 6 3.7 mm2). Among 12 coronary sites with an acute occlusion, 10 sites contained the
echolucent zones, eight of these shallow and two deep, likely representing a lipid-rich core.
In 90 sites without acute events, an echolucent zone in the shallow portion was seen at only
four sites (p , 0.05).
CONCLUSIONS Large eccentric plaque containing an echolucent zone by IVUS can be at increased risk for
instability even though the lumen area is preserved at the time of initial study. Compensatory
enlargement of vessel wall due to remodeling may contribute to the relatively small degree of
stenosis by angiography. (J Am Coll Cardiol 2000;35:106–11) © 1999 by the American
College of Cardiology
Necropsy studies and intracoronary angioscopy have dem-
onstrated that most acute coronary syndromes, including
acute myocardial infarction (AMI) and unstable angina, are
the consequence of rupture or erosion of a preexisting
atherosclerotic plaque with subsequent local thrombus for-
mation (1–4). Prior angiographic studies in patients who
present with an AMI demonstrate that the coronary lumen
is preserved until just before the acute occlusion, often
showing a relatively minor stenosis, typically less than a 50%
reduction in luminal diameter (5–7). Ambrose et al. (7)
reported that minor to moderate luminal irregularities with
an irregular ulcerative contour were the most prominent
angiographic finding predictive of subsequent occlusion.
However, elucidation of the precise morphology of the
atherosclerotic plaque associated with acute coronary syn-
dromes has remained difficult, because angiography provides
only a silhouette of the vessel lumen, not precise intramural
plaque morphology (8).
Intravascular ultrasound (IVUS) enables assessment of
the morphology and distribution of atherosclerotic plaque in
vivo (9,10). Nissen et al. (11) demonstrated that IVUS
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could potentially differentiate stable from vulnerable plaque
by showing a thin intimal leading edge and large intimal
echolucent zones within the plaque. However, it remains
unclear whether IVUS-derived plaque characteristics can be
used to predict subsequent acute coronary events.
Development of a method for prospective identification
of vulnerable plaque would have major clinical implications,
potentially allowing application of coronary interventions
techniques, to prevent subsequent acute occlusion (12).
Therefore, we performed this study to prospectively identify
plaque features associated with subsequent acute coronary
syndromes. In coronary disease patients, a descriptive clas-
sification of their atherosclerotic plaques was performed
using IVUS. Patients were subsequently followed for occur-
rence of an acute coronary syndrome. In those patients with
and without subsequent acute coronary events, plaque char-
acteristics by IVUS were compared to identify morphologic
features of preexisting atherosclerotic plaques predictive of
rupture.
METHODS
Patients. From April 1994 to March 1996, informed
consent for the present protocol was obtained in 112
patients who were admitted for diagnostic or interventional
cardiac catheterization. The principal indications for coro-
nary angiography and IVUS in this cohort were diagnosis of
chest pain (13), effort angina in 88 patients and rest angina
in 24 patients. Because of the requirement for informed
consent, these patients were not consecutive series. There
were 92 men and 20 women with a mean age of 56 years.
IVUS study protocol. After routine catheterization proce-
dures were completed, coronary sites with atherosclerotic
disease were systematically examined by IVUS. The ultra-
sound transducer (30 MHz, 3.5F, Sonicath or 3.2F, Ultra-
cross, Boston Scientific Corporation, Boston, Massachu-
setts) was advanced as distally as possible over a guidewire
(0.014 in.) and withdrawn by a slow manual or mechanical
(1 mm/s) pullback. Wherever a significant atherosclerotic
plaque was observed, pullback was temporarily interrupted
and the plaque carefully examined. Criteria for inclusion of
a plaque in the study database included all of the following:
1) an atheroma thickness .0.5 mm (14), 2) an angiographi-
cally insignificant (,50% diameter) stenosis, and 3) a lesion
not requiring intervention. We included only sites with focal
or segmental lesions, avoiding diffuse atherosclerotic dis-
ease, because of the difficulty in selecting specific individual
sites from a diffusely diseased artery. However, if IVUS
demonstrated the multiple lesions in a single coronary
artery, all such sites were identified and classified.
Precise localization of each interrogated site was accom-
plished using fluoroscopy to identify the IVUS transducer
within the vessel. Identification of the side branches by
IVUS and the presence of a calcified lesion were also helpful
to localize the position of the IVUS transducer. In 72
patients in whom an automatic pullback system was used for
IVUS interrogation, measurement of time from various
landmarks to the target lesion provided a distance
measurement—1 mm 3 time (s). Using the aforementioned
techniques, the angiographic location of all examined sites
was documented. Intravascular ultrasound images were
recorded into s-VHS videotape for measurements.
IVUS measurements. After the procedure, the lesions
were planimetered by the measurement software incorpo-
rated in the ultrasound system (M2400A, Hewlett Packard
or Clearview, Boston Scientific, Boston, Massachusetts).
Lumen area was determined by tracing the boundary be-
tween the lumen and the intimal leading edge. Total vessel
area was determined by tracing the leading-edge of the
media-adventitia boundary. Percent plaque area was com-
puted using the formula: {(total vessel area 2 lumen
area)/total vessel area} 3 100. At the studied sites, the
maximal and minimal thickness of the vessel wall was
measured and an atheroma eccentricity index calculated by
the formula: {(maximal thickness 2 minimal thickness)/
maximal thickness}. The plaque was defined as concentric if
this index was ,0.5 and as eccentric if the atheroma
eccentricity index was $0.5 (14). Calcified lesions were
defined by the presence of echogenic plaque with acoustic
shadowing (15).
Because presence of the lipid-rich core may be an
important requisite for the plaque vulnerability (16), we
particularly searched an intraplaque echolucent zone, de-
fined as an area of low echogenicity with a thickness
.0.3 mm (17). However, we did not classify a plaque as
containing a lipid-rich core if attenuation or acoustic shad-
owing produced the echolucent zone. The position of the
echolucent core within the plaque was defined as “shallow”
if the echolucent zone occupied the half of plaque depth
closest to the lumen, and defined as “deep” if the echolucent
zone was present within the deeper half of the plaque.
Although the thickness of the fibrous cap of the plaque also
may play a role in atheroma vulnerability (3), we did not
measure the thickness of fibrous cap because trailing edge
measurement by ultrasound are confounded by limitations
in axial resolution and ultrasound beam divergence.
Follow-up imaging. We defined the study end points as
the occurrence of an acute coronary syndrome including
myocardial infarction (MI) or unstable angina. All patients
presenting with an acute coronary syndrome during the
follow-up period were subjected to repeat coronary angiog-
raphy to determine the site of acute occlusion and some of
these patients underwent emergent interventional proce-
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
IVUS 5 intravascular ultrasound
MI 5 myocardial infarction
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dures. Patients without acute coronary syndrome were
followed for 24 months after the initial IVUS study. We
retrospectively reviewed the original IVUS images at the
examined coronary sites to evaluate the presence of vessel
remodeling (compensatory enlargement). The total vessel
area at each site and an adjacent proximal reference segment
were measured. The presence of compensatory enlargement
was defined as the total vessel area at the disease site that
was at least 10% larger than the total vessel area at the
corresponding proximal reference site.
Intra- and interobserver variability. The vessel area and
lumen areas of 10 randomly selected disease sites were
measured by two observers and by one observer at two
separate sessions. We also studied 16 other sites to deter-
mine interobserver agreement in the assessment of the
presence of an echolucent zone within the plaque. Results
were expressed as a linear regression correlation coefficient
between the two measurements. Percent error was deter-
mined from the absolute difference between two measure-
ments divided by the initial measurements.
Statistical analysis. Data are expressed as mean 6 stan-
dard deviation. Unpaired Student t test was used for
continuous variables and the chi-square test for categorical
variables. A Cox’s proportional hazard model was used for
the end point of acute coronary syndrome with backward
entry of the following covariates: percent plaque area,
history of smoking, history of hypertension, hypercholester-
olemia and history of diabetes mellitus. A McNemar chi-
square test was used for determining the interobserver
agreement of IVUS evaluation of intraplaque echolucent
zone. We considered the results significant when the p value
was ,0.05.
RESULTS
Analyzed coronary segments. We finally examined 114
coronary sites from 106 patients who met all inclusion
criteria. The remaining six patients were excluded because
of the incomplete follow-up. Among the included patients,
three different coronary sites were examined from one
patient and two different sites from six patients. There were
90 men and 16 women, and mean age was 54 6 10 years.
Eighty-seven patients had stable angina pectoris at the time
of the initial examination. Nineteen patients had a history of
unstable angina and 44 patients had previous MI.
Coronary risk factors included hypertension (systolic
pressure .160 mm Hg and diastolic pressure .90 mm Hg)
in 73 patients, hypercholesterolemia (.250 mg/100 ml) in
60, glucose intolerance in 58 and smoking in 78. The
examined vessels consisted of 64 left anterior descending
arteries, 32 right coronary arteries and 10 left circumflex
arteries. Ultrasound morphology consisted of 92 eccentric
and 22 concentric lesions. Mean percent plaque area was
59 6 12%.
Acute coronary syndromes. During the follow-up period
of 21.8 6 6.4 months (range 1 to 24 months), 16 patients
experienced an acute coronary syndrome. In 12 of these
patients angiography revealed a culprit lesion at the same
sites where the preexisting atherosclerotic disease had been
demonstrated by the IVUS (Figs. 1 and 2). The remaining
four patients showed a culprit lesion in a different vessels
than the artery originally studied at enrollment. The mean
Figure 1. Representative intravascular ultrasound image of vulnerable atherosclerotic plaque. (Left) The right coronary angiography
showed multiple luminal irregularities. (Right) (A) At the distal portion, there existed mild concentric lesion. (B) In the proximal portion
there was a significant eccentric lesion in which the echolucent area with percent plaque area of 67% was seen (arrow). (C) At the very
proximal of this artery, there was also eccentric lesion with relatively high echo density. All three lesions were examined at follow-up.
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follow-up period of these 12 patients was 4.0 6 3.4 months
(range 1 to 8 months). Among these 12 patients, 3 patients
had the history of stable effort angina pectoris, and 9
patients had the history of previous MI at another coronary
site.
Patients with acute coronary syndromes. Since the be-
havior of various plaques within the same patient are likely
not to be independent, we compared only one coronary site
per patient. Therefore, in the one patient who had acute
coronary syndrome at one site out of three examined sites,
the remaining two originally imaged sites were excluded for
comparison. The four patients whose acute coronary syn-
dromes occurred at a coronary site not examined at the
original IVUS study were also excluded. In the six patients
without an acute coronary syndrome in whom two sites were
examined at the original IVUS study, we averaged the
percent plaque area of the two different sites.
In the 12 patients with acute coronary syndrome, the
preexisting disease showed eccentric lesions with the per-
cent plaque area of 67 6 9%. An echolucent zone within the
plaque was found in 10 of 12 sites (Fig. 1). The position of
echolucent zone in this group was shallow in eight sites and
was deep in two sites. A calcified plaque was present at five
coronary sites. At the time of the initial IVUS examination,
the lumen area in this group was 6.7 6 3.0 mm2. Compen-
satory enlargement was observed in 7 of 12 coronary sites.
Patients without acute coronary syndromes. In 90 pa-
tients without an acute coronary syndrome, at IVUS exam-
ination there were 67 eccentric and 23 concentric lesions.
The percent plaque area of these sites was 57 6 12%, which
was significantly smaller than the culprit sites in patients
with an acute coronary syndrome (p , 0.05). The lumen
area in the stable subgroup was 7.5 6 3.7 mm2 at the time
of initial IVUS study. There was no statistically significant
difference in lumen area between the patients with or
without acute coronary syndrome. An echolucent zone was
observed in 19 out of the 90 sites. Strikingly, however, an
echolucent zone located in the shallow portion of the plaque
was observed in only four patients (p , 0.05 compared with
the unstable group). With respect to clinical history in the
patients with an echolucent zone within the plaque, 10
patients had effort angina pectoris, and nine patients had
MI (NS).
There was no statistical difference regarding the risk
factors between two groups. However, nearly all the exam-
ined patients had at least one risk factor. Analysis using
Cox’s proportional hazard model also revealed that the
percent plaque was the significant determinant for the
occurrence of acute coronary syndrome during follow-up
period (Parameter estimate 5 0.070, Standard error 5
0.033, Wald chi-square 5 4.533, p chi-square 5 0.033).
Observer variability. Interobserver correlation coefficient
and the percent error for the total vessel area was r 5 0.99
and 2.3 6 2.0%, respectively. Values for lumen area were
r 5 0.99 and 5.4 6 6.6%, respectively. The intraobserver
correlation coefficient and the percent error were 0.99 and
3.5 6 2.3% for the total vessel area and 0.98 and 4.9 6 4.7%
for the lumen area. As for the accuracy for determination of
intraplaque echolucent zone by IVUS, there was no statis-
tical significance in interobserver agreement (p 5 0.803).
DISCUSSION
In this study, we prospectively followed patients who had
undergone systematic IVUS interrogation of a major epi-
cardial coronary vessel to determine atherosclerotic plaque
morphology. The goal of this study was determination of
the morphologic appearance of the plaque that subsequently
would result in an acute coronary syndrome. Although the
lumen area was preserved at the time of initial examination,
plaques that ultimately caused an acute coronary syndrome
exhibited a relatively large plaque volume and were strik-
ingly eccentric in plaque distribution. Furthermore, we
frequently observed an echolucent zone close to the luminal
surface (shallow location) in plaques that ultimately became
unstable.
Necropsy studies have suggested that among the deter-
minants of the plaque vulnerability, the size of plaque area
was less significant than the presence of lipid-rich core (16).
However, a recent angiographic study demonstrated that
coronary stenosis rapidly increased prior to the onset of
acute coronary syndrome (18,19). Under these conditions,
the severity of the preexisting atherosclerotic disease may be
an important factor in accelerating luminal occlusion. Ac-
cording to the concept of coronary remodeling originally
proposed by Glagov et al. (20), the coronary lumen is usually
preserved until the plaque involvement reaches about 40%
of the vessel circumference. Lim et al. (21) demonstrated
that compensatory enlargement occurs in approximately
80% patients examined by IVUS, as observed in this study.
Therefore, it remains possible that the coronary stenosis
Figure 2. Coronary angiography before and after emergent angio-
plasty. Three months after registration, the patient had acute
inferior myocardial infarction. Under these conditions (A) the
coronary artery was totally occluded at the portion where the
eccentric plaque with echolucent area had been seen by ultrasound.
(B) Emergent balloon angioplasty that was done at the site of total
occlusion resulted in complete recanalization of this artery.
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becomes unstable when the plaque volume exceeds the
capacity of compensation (22). Under these conditions, a
remodeled atheroma may be vulnerable to mechanical forces
leading to plaque rupture (23,24). In the presence of vessel
remodeling, it is reasonable that angiography underesti-
mates the disease severity.
We frequently observed an echolucent zone within the
plaques that eventually became unstable. A recent clinico-
pathologic study indicated that the echolucency of the
plaque could represent the presence of a lipid-rich core (17)
where metaloproteinases are associated with erosion of the
fibrous cap (25). Therefore, one might speculate that the
presence of the echolucent zone might be indicative of
plaque vulnerability. Other methods such as analysis of
plaque composition by ultrasonic tissue characterization
(26), atheroma temperature (27) or tissue reflection in the
near infrared spectrum (28) may prove helpful to identify
the lipid-rich core and plaque vulnerability.
The eccentric plaque distribution appears to be more
vulnerable than the concentric disease (1–3). This is likely
related to the mechanism of the plaque rupture. We
previously reported that the eccentric plaque had heteroge-
neous vessel wall distensibility (29) that could represent a
mechanical factor in plaque rupture (30).
Clinical implications and limitations. The ability to iden-
tify vulnerable plaque has major clinical implications, since
acute coronary syndromes including sudden death represent
the leading cause of morbidity and mortality in modern
civilizations. The present data demonstrate the increased
risk of rupture for an eccentric atheroma with a relatively
large plaque burden and a shallow echolucent zone which
are observed by IVUS. If confirmed by further studies, this
observation may allow selection of specific patients for very
aggressive risk factor interventions to reduced morbidity and
mortality (31).
There remain limitations of our study. First, the precise
mechanism of the acute coronary event remains unclear,
because we did not perform the IVUS examination at the
time of the acute coronary syndrome. The repeated IVUS
examination in the setting of an evolving acute coronary
syndrome may demonstrate the mechanism of the occlu-
sion, although we did not believe it appropriate to perform
intracoronary examination prior to reperfusion.
Second, in view of the intervals ranging one to eight
months between the initial IVUS examination and the
development of acute coronary syndromes, the lesions may
have changed in composition during these periods. Accord-
ingly, it remains possible that a plaque could increase in the
size or the echolucent zone could expand through in-
traplaque necrosis. Conversely, the size of these lipid-rich
zones may decrease as plaque fibrose or calcify. Serial IVUS
observation in such patients would be required to demon-
strate changes in the plaque composition during the disease
process. To statistically account for the variable length of
follow-up, we applied Cox’s proportional hazard model with
percent plaque area and patients’ risk factors as variables.
However, the small number of patients who exhibited acute
coronary syndrome limits any conclusions from this analysis,
although this analysis revealed importance of percent plaque
area for possible occurrence of acute coronary syndrome.
Finally, this study was not performed in a truly random-
ized fashion, because we could only examine the patients in
whom informed consent was obtained. Further study with
multicenter, randomized design will be required to fully
elucidate IVUS morphology in the atherosclerotic plaque
associated with acute coronary syndrome.
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